1 Using a grease-gap technique, we studied the action of histamine on the d.c. potential recorded between the internal carotid nerve and the main body of the isolated superior cervical ganglion of the rat. 2 A small, slow depolarization was evoked by 10-300 /M histamine. This response was not reduced by lowering the calcium concentration in the superfusing medium (from 2.5 to 0.1 mM), or by superfusing tetrodotoxin, N-methylatropine, or propranolol (all at 1 pM). 3 Mepyramine (10nM) antagonized this depolarization, but cimetidine (10pM), metiamide (30,UM), burimamide (1IOuM) and impromidine (1 pM) did not. Two other agonists also evoked a mepyramine-sensitive slow depolarization. The rank order of potencies was histamine > Ne-methyl-histamine > 2-methyl-histamine.
Introduction
It is now well established that there is more than one type of receptor for histamine. In 1966, Ash & Schild defined the H1 receptor as being sensitive to low concentrations of antihistamine drugs (the pA2 for mepyramine was >9). In 1972, Black et al. characterized the H2 receptor using a novel selective antagonist, burimamide (Kb = 7 x 10-6 M). Subsequently H, receptors were shown to be linked to inositol phospholipid turnover (Subraminian et al., 1980; Daum et al., 1983 ) and H2 receptors were reported to mediate an inhibition of adenylyl cyclase (Hegstrand et al., 1976) . The finding that histamine could inhibit its own release from brain slices (Arrang et al., 1983) prompted the suggestion of another receptor. This H3 receptor was clearly demonstrated by use of the selective agonist (R)-a-methyl-histamine and the selective antagonist thioperamide (Arrang et al., 1987) . At the same time, the H3 receptor was demonstrated to mediate the histamine-induced inhibition of transmitter release in the guinea-pig mesenteric artery (Ishikawa & Sperelakis, 1987) . In this preparation the H2 antagonists cimetidine and metiamide were weak antagonists (Kb> 30pM), whereas impromidine and burimamide had relatively high antagonist affinities (Kb s of 48 and 330 nM, respectively). The antagonist action of impromidine was intriguing since it was initially reported to be a potent H2 receptor partial agonist (Ganellin, 1982) .
The first neuronal actions of histamine to be described were a direct stimulant action on the feline superior cervical ganglion in situ and a facilitation of transmission across its synapse (Trendelenburg, 1954; 1957) . The former action was shown to be sensitive to mepyramine before the H1 receptor was defined (Trendelenburg, 1954) . A facilitation of transmission through the rabbit superior cervical ganglion was shown to be mediated by H1 receptors but a depression of transmission in the same preparation was blocked by an H2 antagonist (Brimble & Wallis, 1973) . The activation of H1 receptors on sympathetic neurones, and the subsequent release of noradrenaline, is thought to mediate the pressor action of intravenous histamine in the guinea-pig (Krstic, 1988) . Recent intracellular studies in the guinea-pig superior cervical ganglion have revealed that the H, receptor mediates a depolarization associated with an increase in the neuronal input resistance (Christian et al., 1989) . On the rat superior cervical ganglion, however, histamine-induced depolarizations have been reported to be small or absent (Watson, 1970) , but, as seen on the rabbit ganglion, an H1-mediated facilitation and an H2-mediated depression of transmission have been observed (Snow & Weinreich, 1987) .
We observed that histamine does induce a small, slow depolarization of rat superior cervical ganglion cells in vitro. This paper describes our investigation of the pharmacology of this slow response which was compared with that of a fast depolarization induced by relatively high concentrations of histamine.
Methods
Male Sprague-Dawley rats (150-200g) were killed by stunning followed by exsanguination. Two superior cervical ganglia were excised from each animal. Each ganglion was desheathed and set up in a three compartment bath as previously described (Newberry & Priestley, 1987 NaCi 125, NaHCO3 25, D-glucose 10, CaCl2 2.5, KCl 2, KH2PO4 1 and MgSO4 1, and was equilibrated with 5% CO2 in 02 .
Histamine (100pM) was applied to the ganglion body via the perfusion system for min every 45 min until two equal responses were obtained. After the recovery of the last of these responses, the ganglion was superfused with an antagonist for one hour or, as a control, the ganglion was superfused with unadulterated medium for the same length of time. The concentration-response relationship of an agonist was then determined by 1 min superfusions at intervals of 45-60 min, in an ascending order of concentration. The peak responses of the agonists were expressed as ratios. They were related to the depolarization evoked by the last application of histamine prior to the 1 h incubation. This protocol was rigidly adhered to for the reasons given in the Results. The relative response of a given concentration of agonist on a number of ganglia was cumulated as the geometric mean (± s.e.mean).
To confirm the antagonist properties of a given compound on GABAA and nicotinic responses, we determined its IC50 against 10puM GABA and 30Mm 1,1-dimethyl-4-phenylpiperazinium (DMPP), respectively. The IC50 was the concentration necessary to reduce the approximately half-maximal agonist response by 50%.
Burimamide, metiamide, impromidine trihydrochloride, N'-methyl-histamine dihydrochloride and 2-methyl-histamine dihydrochloride were kind gifts from Smith, Kline and French. Histamine dihydrochloride, mepyramine (pyrilamine) maleate, cimetidine, (+ )-tubocurarine chloride, Nmethylatropine nitrate, propranolol, y-aminobutyric acid, 1,1-dimethyl-4-phenylpiperazinium iodide and N-methylbicuculline chloride were obtained from Sigma Chemical Company. The last was also supplied by Research Biochemicals Inc., as was mecamylamine. Tetrodotoxin was purchased from Sankyo.
An n number refers to the number of ganglia, each from a different rat, which were tested under a particular condition.
Results
Histamine (10-300#M) routinely induced a small, slow depolarization of the rat superior cervical ganglion. To obtain the largest response to a given concentration of histamine, it was necessary to superfuse it for 2min. However, the response to histamine was prone to long-lasting tachyphylaxis (see Figure  la) . To try to avoid this, it was necessary to apply histamine for 1 min periods every 45 to 60 min. The min application produced about 90% of the response to that of the 2 min superfusion. Although tachyphylaxis was not evident with this protocol, the response to a given concentration of histamine increased gradually throughout the day. Consequently, the effect of an antagonist on the histamine dose-response curve could only be realistically determined if the same protocol was performed during every experiment. The ganglia incubated with an antagonist could then be compared with untreated ganglia (see Methods). Without this methodology, it was only possible to assess whether an antagonist affected the response to one or two concentrations of histamine.
The slow depolarizing response to 300pM histamine (1 min)
was not depressed by 1Mm tetrodotoxin (n = 2) or by lowering the calcium chloride concentration in the medium to 0.1 mm (n = 4). This response was unaffected by a 30 min superfusion of the ganglion with propranolol or N-methylatropine (1 MM, n = 4 each). It was also undiminished by the H2 antagonists, cimetidine (10pM, n = 2) and metiamide (30pM, n = 4) and the H2/H3 receptor compounds impromidine (1 Mm, n =4) and burimamide (10pM, n = 4). None of these compounds had a direct action by itself. In particular, the H2 agonist impromidine did not evoke a direct response when superfused at 10M
for 1 min (n = 2). In contrast the H, antagonist mepyramine (lMm, 30min) largely abolished the slow depolarization to 300pM histamine (see Figure lb) . agonists Ne-methyl-histamine and 2-methyl-histamine also evoked the slow depolarization (see Figure ic) .
The dose-response curve to histamine is illustrated in Figure 2 . It appeared to begin to level off at about 100-300pM, but clearly started to rise again at greater than 1 mM.
Mepyramine (0.01, 0.1 and lJMM) antagonized the response to concentrations less than 300 Mm, but the responses to greater than 1 mm were less affected. The dose-response curves to 2-methyl-histamine and, in particular, Ne-methyl-histamine were also biphasic (Figure 3 10,00
Agonist (>M) Figure 3 Concentration-response curves of the depolarizations to histamine (-), Ne-methyl-histamine (0) and 2-methyl-histamine (*) on the rat superior cervical ganglion. Accumulated data of the agonists were from 5, 7 and 6 different ganglia, respectively. the rank order of potency of the three agonists was histamine > Ne-methyl-histamine > 2-methyl-histamine (see also Figure Ic ), but with concentrations of over 1 mm the ranking was Ne-methyl-histamine > histamine z 2-methyl-hista- mine. Mepyramine (10 nM) antagonized the responses to <300juM of both Ne-methyl-histamine and 2-methyl-histamine to a similar extent to that seen with <300pM histamine (not shown, n = 4 for each). An examination of the responses (Figure 4) revealed that a fast depolarization was evoked by high concentrations of histamine, and particularly by NImethyl-histamine.
Appropriate controls were sought when it was discovered that 3 mm histamine dihydrochloride reduced the pH of the superfusing medium from ca. 7.4 to ca. 7.0. (A similar drop in pH was noted with 3 mM N'-methyl-histamine dihydrochloride). Control solutions were prepared by adding sufficient hydrochloric or sulphuric acid to similarly reduce the pH. When superfused for 1 min periods, these solutions evoked apparent fast depolarizations, but the responses were only 22-56% (median = 26, n = 5) of the response to 3mM histamine recorded in the presence of 1 RM mepyramine. Furthermore, in experiments where the pH of the solutions containing either histamine or N'-methyl-histamine (3mM) was kept at 7.4 (by adding sufficient 0.5 M NaOH) the fast depolarizing response was still present, although it was 33-40% smaller than that recorded without adjusting the pH (n = 3). Given that the agonist pharmacology of the fast response appeared to be different from that of the smaller slow response, we determined the sensitivity of the response to 3 or 10mM histamine to a range of antagonists. Using such high concentrations of histamine, we repeated the responses at intervals of 1 h or greater and superfused each antagonist for 30-45 min. The fast response was not reduced by the histamine antagonists cimetidine (10Mm, n = 4), impromidine (1 pM, n = 4) and burimamide (10gM, n = 4). It was also unaffected by N-methylatropine (1 pM, n = 8), propranolol (1 pm, n = 4) or mecamylamine (10puM, n = 6). At the present time, the only antagonists of this response are (+)-tubocurarine (100pM, n = 6, 0-25%) and N-methylbicuculline (100pM, n = 7, 30-45%, see Figure 5 ). At this concentration, the latter did not reduce the slow depolarization to 300pM histamine (n = 4). The reduction of the fast response by N-methylbicuculline was observed in the presence or absence of mepyramine (1 pM).
By contrast with their action on the fast histamine response, the geometric mean IC50 values for mecamylamine and (+)-tubocurarine against DMPP were 0.7 and 30pm, respectively (n = 4 for each). N-methylbicuculline and (+)-tubocurarine antagonized the GABA-induced depolarization (n = 4) with IC50s of 2 and 17 pm, respectively. Finally, in contrast to the lack of action on the histamine-induced fast response, lowering the calcium in the medium (from 2.5 to 0.1 uM) reduced the nicotinic depolarization to DMPP by 50-75% (n = 4).
Discussion
The principal finding of this study was that histamine (10-300pM) evoked a small, slow depolarization of the rat superior cervical ganglion that was sensitive to mepyramine. At concentrations greater than 1 mm it also induced a larger, faster depolarization which did not appear to be mediated by H1, H2 or H3 receptors. The rank order of potency of agonists to evoke the slow depolarization was different from that necessary to induce the fast depolarizing response.
The slow depolarization to histamine appeared to be a direct action on the ganglion cells since it was not reduced by tetrodotoxin or by reducing the calcium concentration in the medium, either of which would reduce synaptic transmission. Slow ganglionic depolarizations can also be evoked by muscarinic receptors and fl-adrenoceptors, but this histamine action was unlikely to be mediated by these receptors because of its resistance to N-methylatropine and propranolol. Thus, this response was probably mediated by a direct action of histamine on histamine receptors.
The sensitivity of the slow depolarization to mepyramine (estimated pA2 of 9) and the lack of effect of H2 and H3 antagonists indicated that it was mediated by H1 receptors. Two other histamine analogues Ne-methyl-histamine and 2-methyl-histamine also evoked a slow mepyramine-sensitive ganglionic depolarization. They were about 3 and about 10 times less potent than histamine, respectively.
Relatively high concentrations of histamine also evoked a fast depolarization. This was initially considered to be a nonspecific action since such concentrations of histamine dihydrochloride reduced the pH of the superfusing medium. Comparable pH controls did evoke similar fast depolarizations, but these responses could only account for ca. 25% of the response to histamine. In addition, the fast response was still present when the pH was kept at 7.4. This complication, however, should be borne in mind when considering the pharmacology of the histamine-induced fast depolarization, since the pH of the medium was not routinely restored to 7.4.
The peak of the dose-response curve for the fast depolarization was not determined, but it was clearly much larger than that of the slow depolarization. The rank order of potency of the agonists in producing this response was different from that for the slow depolarization. NI-methyl-histamine was about 3 times more potent than the other 2 agonists which were approximately equipotent. This potential change was not only insensitive to muscarinic and fl-adrenoceptor antagonists, but it was also unaffected by the H1, H2 and H3 antagonists tested. Mepyramine did reduce the peak of the fast response to these concentrations of histamine, but its IC50 (0.1-1.O0Mm) was clearly greater than that against the slow response evoked by lower concentrations of histamine (IC50 ca. 10nm, see Figure 2 ). Indeed, the antagonism of the fast response could be explained partly by a reduction of the underlying slow response.
A fast depolarization of this preparation can be evoked by the activation of nicotinic, GABAA and 5-HT3 receptors, so we first considered whether histamine could be activating one of these receptors. It is known that histamine interacts with the nicotinic receptor at the neuromuscular junction, albeit in an apparently competitive antagonist manner (Ariyoshi et al., 1985), but we tested for the possibility that it could activate a nicotinic response on this preparation. The resistance of this response to mecamylamine and the small effect of (+ )-tubocurarine indicated that the opening of nicotinic receptor-linked ion channels was improbable. Furthermore, unlike the depolarization to the nicotinic agonist DMPP, the fast histamine response was not reduced by superfusing low calcium containing medium. The relative resistance of the fast histamine response to (+)-tubocurarine was very informative. In addition to its antinicotinic properties, it also antagonizes 5-HT3 (Yakel & Jackson, 1988) and GABAA (Simmonds, 1986) receptor-mediated responses, so the fast histamine response was unlikely to be mediated by such receptors. It was therefore surprising when another GABAA antagonist, Nmethylbicuculline, reduced this response; however, the concentration used (100pM) was well above its affinity for GABAA receptors (pA2 5.9, Simmonds, 1986) and its IC50 value against the GABA response on this preparation (2pM).
The pharmacology of the histamine-induced fast depolarization was distinct from that of H1, H2 and H3 receptors, but considering the problems of interpretation arising from the pH changes and the absence of a potent and selective antagonist, it would be premature to conclude that this response was mediated by 'H4' receptors. N-methylbicuculline did reduce the fast response without blocking the underlying slow depolarization, but its apparent affinity was low. We know of no other fast response to histamine on mammalian tissues which has this agonist and antagonist pharmacology, but histamine has been shown to evoke fast chloride-mediated responses on fly photoreceptors (Hardie, 1989) and lobster olfactory receptor neurones (McClintock & Ache, 1989) . It is possible that the fast histamine-induced response of the rat superior cervical ganglion is mediated by a similar mechanism, since the opening of chloride channels (e.g. by GABA, Adams & Brown, 1975) will depolarize these cells. Quite clearly, however, further experiments are necessary before any conclusions can be drawn.
It has been shown that H2 receptors mediate a depression of transmission across the rabbit (Brimble & Wallis, 1973) and rat (Snow & Weinreich, 1987) superior cervical ganglion. We found no evidence for an H2-mediated change in the membrane potential of these cells: H2 antagonists had no effect on the potential changes evoked by histamine and the H2 receptor agonist, impromidine, evoked no response by itself. Consequently, our evidence would support the conclusion of Snow & Weinreich (1987) that the depression of transmission is likely to be mediated presynaptically.
In conclusion, a small slow depolarization to histamine was recorded from the rat superior cervical ganglion. This response was probably mediated via H1 receptors. It could contribute to the facilitation of transmission previously observed on this preparation (Snow & Weinreich, 1987) . High concentrations of histamine also evoked a large, fast depolarization, but the pharmacology of this response was unlike that of H1, H2 or H3 receptors.
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